|
Update Series (2025) Lesson 36: Nonantibiotic Strategies for Urinary Tract Infection Prevention in Women |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. |
|
Update Series (2025) Lesson 37: Case Studies in Ejaculatory Dysfunction |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. |
|
Update Series (2025) Lesson 38: Long-Term Follow-up Considerations in Testicular Cancer |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. |
|
Global Perspectives in Urothelial Carcinoma (2025) – Japan Focus Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
|
Self-Assessment Study Program SASP (2026) |
|
|
|
$785.00 |
|
|
The Latest Breakthroughs in LG-IR-NMIBC (2025) Webcast/Podcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
|
AUA Coding Seminar Webcast (2025) |
|
|
|
$725.00 |
AUA Coding Seminar Webcast (2025) - Practice Managers' Network Subscribers enter PMN2025ONL at checkout to receive AUA member rate -The Patient Journey: Unlocking the Power of Coding and Billing in Revenue Cycle Management (RCM)Please Note: This educational activity is non-CME and non-CEU |
|
The Latest Breakthroughs in mHSPC (2025) Webcast/Podcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
In response to critical insights from the American Urological Association's (AUA) Advanced Prostate Cancer Global Needs Assessment, the AUA proud to present The Latest Breakthroughs in Metastatic Hormone Sensitive Prostate Cancer (mHSPC). |
|
Self-Assessment Study Program SASP (2026) Online + App - Single User |
|
|
|
$375.00 |
|
|
Self-Assessment Study Program SASP (2026) 5-Year Bundle Online + App - Single User |
|
|
|
$785.00 |
|
|
Global Perspectives in Urothelial Carcinoma (2025) – LATAM Focus Portuguese Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
|
Global Perspectives in Urothelial Carcinoma (2025) – LATAM Focus Spanish Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
|
Annual Review Course Syllabus (2026) |
|
|
|
$226.00 |
Annual Review Course Printed Syllabus* - Guarantee Your Copy by Ordering by May 8, 2026!The Annual Review Course Syllabus is a hard copy, black and white compilation of the 2026 presentations. |
|
Annual Review Course Webcast Upgrade (2026) |
|
|
|
$315.00 |
Purchase our Most Popular Option by bundling the Live Course Only AND Webcast Upgrade!This discounted activity is only available for attendees of the Live Course Only. |
|
LG-IR-NMIBC Treatment Landscape Podcast (2025) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need for additional education in bladder cancer, the AUA has developed AUA Expert Exchange Podcast Series: Bladder Cancer Treatment Landscape. To address the educational needs of the urologic care team, this episode will focus on:LG-IR-NMIBC Treatment LandscapeACKNOWLEDGEMENTS:Support provided by independent educational grants from: AstraZenecaJohnson & Johnson |